Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 436Osteosarcoma 132Sarcoma, Ewing 89Melanoma 80Rhabdomyosarcoma 77Neoplasms 71Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Breast Neoplasms 61Ovarian Neoplasms 60Colorectal Neoplasms 60Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 52Dendritic Cell Sarcoma, Interdigitating 45Carcinoma, Non-Small-Cell Lung 43Leiomyosarcoma 42Gliosarcoma 42Stomach Neoplasms 41Pancreatic Neoplasms 41Lymphoma 36Uterine Cervical Neoplasms 35Sarcoma, Synovial 35Carcinoma, Renal Cell 35Rhabdoid Tumor 34Neurofibrosarcoma 34Lung Neoplasms 34Glioma 34Sarcoma, Kaposi 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Sarcoma × 1 year × Clear all
NCT05915208 2025-06-11

Histiocytic Disorder Follow-up Study

University of Alabama at Birmingham

Recruiting
6,000 enrolled
MyeloidSarcoma

Histiocytosis, Langerhans-Cell, Histiocytosis, Histiocytosis, Sinus, Neoplasms, Second Primary, Erdheim-Chester Disease, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡